MMP1 and breast cancer: Further studies indicated that the TPA dose-dependently enhanced the expression levels of MMP-1 and MMP-9 via inducing phosphorylation of PKC-α (99), and BBR administration could suppress TPA-induced proliferation and formation of BC cells via blocking PKC-α/MMP signaling (100, 101).